Re: Health Authorities Now Admit Severe Side Effects of Vaccination

[Guest guest]

Does anyone else ever get the

feeling that the lunatics have taken over the asylum?

Frances of Melbourne, au

Mike Shea wrote:

 

 

Another

corporate boondoggle or just bad luck………………………..

 

This

article may be reprinted free of charge

provided 1) that there is clear attribution

to the Orthomolecular Medicine News Service,

and 2) that both the OMNS free subscription

link http://orthomolecular.org/subscribe.html

and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml

are included.

FOR

IMMEDIATE RELEASE

Orthomolecular

Medicine News Service, March 20, 2012

Health

Authorities Now Admit Severe Side Effects of

Vaccination

Swine

Flu, Pandemrix and Narcolepsy

by

Karin Munsterhjelm-Ahumada, M.D.

(OMNS,

March 20, 2012) The swine flu pandemic of

2009 was caused by a type A influenza (H1N1)

virus. This virus was originally referred to

as "swine flu" because many of the genes of

this new virus were very similar to

influenza viruses that normally occur in

pigs in North America. The H1N1 virus is

genetically similar to the 1918 pandemic

virus, as determined from victimes of the

latter who were buried, and later

disinterred, in Svalbard. It was responsible

for most of the outbreaks up until 1956 and

then disappeared.

However,

this new virus was actually quite different

from the typical swine flu viruses. This

virus first caused illness in Mexico and the

United States in March and April, 2009. This

novel H1N1 flu spread from person to person,

unlike typical swine flu. In 2009 vaccines

were being developed for the prevention of

swine flu in humans. http://www.medterms.com/script/main/art.asp?articlekey=99584

On

11 June 2009, the World Health Organization

(WHO) declared that the swine flu had

developed into a full scale world epidemic -

a pandemic alert to Phase 6. Margaret Chan,

the Director-General of WHO, commented on

the situation in a somewhat ambiguous way.

While stressing that the swine flu had

reached a serious pandemic level, she

declared later in the same statement that

the illness seemed to be mild and that most

of the patients would recover without

medical intervention. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html

The

world chose to listen to the first part of

her message.

Two

pharmaceutical companies GlaxoKline

(GSK) and Novartis had, under considerable

time pressure, developed a vaccine against

the swine flu. Since the cultivation of an

adequate amount of virus to generate the

vaccine requires time, GSK and Novartis

decided to formulate a weaker vaccine but

strenghten it with an adjuvant that contains

squalene. Immunologic adjuvants are

substances, administered in conjunction with

a vaccine, that stimulate the immune system

and increase the response to the vaccine http://www.who.int/vaccine_safety/topics/adjuvants/squalene/questions_and_answers/en/.

Although squalene is a natural substance

found in methabolic pathways of the body,

its inclusion in a vaccine is controversial

and it is not in use in the USA.

On

25 September 2009, the European Medicines

Agency (EMEA) approved Pandemrix, the swine

flu vaccine produced by GSK and Focetria

produced by Novartis. http://justthevax.blogspot.com/2009/09/eu-approves-gsk-pandemrix-and-novartis.html

The vaccine would be ready for use that

October.

In

Sweden, Finland, Norway and Iceland, the

authorities explicitly set the goal of

vaccinating the entire population http://www.svd.se/nyheter/inrikes/massvaccinering-raddade-sex-liv_6851143.svd.

In this respect, it is of interest that the

governments of these countries, already

before the outbreak of the swine flu, had

concluded an agreement with GSK, according

to which they were assured the delivery of

pandemic vaccines, if needed. In addition,

the contract stipulated that, in a situation

characterized as a pandemic by the WHO, the

same Nordic countries would have ten days to

decide whether or not to accept delivery of

the vaccine in question. Hence, the purpose

of the agreement was to assure that the

entire populations of these countries would

receive vaccinations. Finally, the contract

protected GSK from any claim for financial

compensation in case the delivered vaccine

would have any side effects.

When

WHO declared the swine flu to be a Phase 6

pandemic, the agreement referred to above

was automatically activated.

Mass

vaccination started in Finland and Sweden in

October 2009. In order to cover the largest

possible percentage of the population, the

authorities initiated an enormous public

relations campaign, which could be described

in terms of a "moral persuasion." Solidarity

became the slogan: "Be vaccinated to protect

your fellow citizens." Those who questioned

the vaccination program (small groups of

vaccine opponents or just people who were

hesitant) were looked upon with disapproval.

In

contrast to these vaccine - enthusiastic

countries, the politics of vaccination

within the rest of the European Union varied

immensely among its member states. Poland,

for example, decided not to buy vaccines at

all due to the strict agreement conditions

required by the pharmaceutical companies.

Denmark's order covered only "risk groups".

http://www.svd.se/nyheter/inrikes/svd-granskar-sveriges-vaccinering-mot-svininfluensan_6843475.svd

The

expected second wave of the influenza never

appeared. The epidemic gradually declined

during the first half of 2010. The same

year, on 10 August, WHO officially declared

the end of the epidemic. The European Center

for Disease Prevention and Control (ECDC)

stated that the swine flu was less dangerous

and had a lower mortality rate than the

seasonal influenza. Thus, apparently the

swine flu would not have been a dangerous

epidemic even without the mass vaccination.

Interestingly, also that same year, vitamin

D was shown to prevent influenza in

children. (1)

In

Sweden, 60% of the population had been

vaccinated, while in Finland 50% was

covered. In contrast, the figures in Germany

and Poland were only 8 and 0% respectively.

In the history of Swedish health care this

pandemic campaign amounted to one of the

most expensive ever. Enormous amounts of

taxpayer money were at stake. http://www.svd.se/nyheter/inrikes/svd-granskar-sveriges-vaccinering-mot-svininfluensan_6843475.svd

Meanwhile,

the media had become silent on this issue ;

there was no further discussion about the

swine flu anymore.

Then

the blow came:

"The

absolutely worst thing that could happen,"

commented Bergström, the Director -

General of the European Federation of

Pharmaceutical Industries and Associations,

EFPIA. "The worst nightmare of both the

industry and the health authorities is an

illness that turns out to be mild, while the

vaccine that was supposed to prevent a

dangerous epidemic causes a severe side

effect that was previously unknown." http://www.kostdemokrati.se/nyheter/files/2012/02/SvD-sid-14-19.pdf

In

August 2010, Finland reported an increased

occurrence of narcolepsy in children and

youngsters vaccinated with Pandemrix. On 1

September 2010, Finland stopped all

Pandemrix vaccinations. http://articles.mercola.com/sites/articles/archive/2010/09/10/swine-flu-vaccine-may-have-caused-narcolepsy.aspx

Narcolepsy

is a severe chronic neurologic disease that

not only results in a disabling fatigue,

which typically results in the patient

falling asleep anywhere and at any time. It

might also lead to panic attacks and a state

of exhaustion. For many, the worst

consequences are the symptoms of cataplexy.

This condition causes the narcolepsy

patient, when expressing strong feelings

such as laughter or crying, to suddenly lose

muscular control. The legs give way, speech

gets slurred, the gaze goes unfocused and

the person gives the impression of being

drunk. In some patients, frightening

hallucinations appear when falling asleep or

waking up.

On

1 September 2011, the Finnish National

Institute for Health and Welfare (THL)

admitted, that for Finnish children and

youngsters age 4-19, there was a new and

obvious connection between Pandemrix and

narcolepsy. As stated in THL's press

release, "The increased risk associated with

vaccination amounted to six cases of

narcolepsy per 100,000 persons vaccinated in

the 4-19 age group during the eight months

following vaccination. This was 12.7 times

the risk of a person in the same age group

who had not been vaccinated." http://www.thl.fi/en_US/web/en/pressrelease?id=26352

This statement was made almost exactly two

years after the THL's earlier statement made

in the midst of the swine flu hysteria that

everyone should be vaccinated with Pandemrix

and that it would be safe. In that original

statement, the director of the THL

emphasized that the squalene adjuvant could

increase the side effects of the vaccine to

some extent. However, he stated, these side

effects would not be dangerous. http://www.tohtori.fi/?page=5833192 & id=0169960

In

Sweden, at least 150 children are now

suffering from narcolepsy caused by

Pandemrix vaccine. In Finland, the number is

approximately 100. In both countries the

number is probably growing. Narcolepsy is a

disease with lifetime consequences, and the

risk that Pandremix may have caused other

neurological illnesses has not yet been

excluded. Many have already began to compare

this tragedy with the thalidomide

catastrophe. http://www.svd.se/nyheter/inrikes/medicinsk-tragedi-med-ett-absurt-slut_6861775.svd

No

European countries had a particularly high

rate of deaths due to the swine flue.

Germany had the same death rate as Sweden,

which was 0.31/100 000, although Sweden

vaccinated 60% and Germany only 8%. This

implies that the vaccine did little to

prevent deaths. The responsible authorities

have not yet commented on this matter of

fact. http://www.svd.se/nyheter/inrikes/massvaccinering-raddade-sex-liv_6851143.svd

Last

year the Finnish government promised full

compensation for those who have developed

narcolepsy as a consequence of the

vaccination. http://www.bloomberg.com/news/2011-10-05/finnish-government-to-compensate-pandemrix-narcolepsy-victims.html.

While Sweden did, indeed, follow the Finnish

THL in admitting the connection between the

vaccine and the disease, the Swedish

authorities have not yet decided whether and

how to provide appropriate compensation.

In

February 2012, Svenska

Dagbladet, a widely read

newspaper in Sweden, presented an

informative and accurate series of articles

on this theme. They describe some of the

affected children narrating how difficult it

is to live with narcolepsy http://www.svd.se/nyheter/multimedia/artikel_6840743.svd

According

to the authorities, much research is still

underway concerning the details of the

vaccine injury. Taking the pressure from the

public and the affected families into

account, it will be difficult for them to

avoid carrying out a thorough investigation.

Let's hope so.

 

References:

1.

Urashima M, Segawa T, Okazaki M, Kurihara M,

Wada Y, Ida H. Randomized trial of vitamin D

supplementation to prevent seasonal

influenza A in schoolchildren. Am J Clin

Nutr. 2010 May;91(5):1255-60.

 

Nutritional

Medicine is Orthomolecular Medicine

Orthomolecular

medicine uses safe, effective nutritional

therapy to fight illness. For more

information: http://www.orthomolecular.org

 

Find

a Doctor

To

locate an orthomolecular physician near you:

http://orthomolecular.org/resources/omns/v06n09.shtml

 

The

peer-reviewed Orthomolecular Medicine News

Service is a non-profit and non-commercial

informational resource.

 

Editorial

Review Board:

Ian

Brighthope, M.D. (Australia)

Ralph K. , M.D. (USA)

Carolyn Dean, M.D., N.D. (USA)

Damien Downing, M.D. (United Kingdom)

Dean Elledge, D.D.S., M.S. (USA)

Ellis, M.D. (Australia)

P. Gallagher, M.D., D.C. (USA)

, D.Sc., Ph.D. (Puerto Rico)

B. Grant, Ph.D. (USA)

Steve Hickey, Ph.D. (United Kingdom)

A. , Ph.D. (USA)

Janson, M.D. (USA)

E. , D.C. (USA)

Bo H. Jonsson, M.D., Ph.D. (Sweden)

Levy, M.D., J.D. (USA)

Stuart Lindsey, Pharm.D. (USA)

R. Miranda-Massari, Pharm.D. (Puerto

Rico)

Karin Munsterhjelm-Ahumada, M.D. (Finland)

Paterson, M.D. (Canada)

W. Todd Penberthy, Ph.D. (USA)

Gert E. Schuitemaker, Ph.D. (Netherlands)

G. , Ph.D. (USA)

Jagan Vamanan, M.D. (India)

W. Saul, Ph.D. (USA), Editor and contact

person. Email: omns@...

Readers may write in with their comments and

questions for consideration for publication

and as topic suggestions. However, OMNS is

unable to respond to individual emails.

 

To

Subscribe at no charge:

http://www.orthomolecular.org/subscribe.html

To

Unsubscribe from this list:

http://www.orthomolecular.org/unsubscribe.html